| Combination of ipilimumab and nivolumab in cancers: from clinical practice to ongoing clinical trials O Kooshkaki, A Derakhshani, N Hosseinkhani, M Torabi, S Safaei, ... International journal of molecular sciences 21 (12), 4427, 2020 | 93 | 2020 |
| Immune checkpoints and CAR-T cells: the pioneers in future cancer therapies? N Hosseinkhani, A Derakhshani, O Kooshkaki, M Abdoli Shadbad, ... International Journal of Molecular Sciences 21 (21), 8305, 2020 | 86 | 2020 |
| The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: lessons learned and the road ahead N Hosseinkhani, A Derakhshani, MA Shadbad, A Argentiero, V Racanelli, ... Frontiers in Immunology 12, 676181, 2021 | 43 | 2021 |
| A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery MA Shadbad, Z Asadzadeh, A Derakhshani, N Hosseinkhani, ... Biomedicine & Pharmacotherapy 143, 112213, 2021 | 22 | 2021 |
| A systematic review and meta-analysis on the significance of TIGIT in solid cancers: Dual TIGIT/PD-1 blockade to overcome immune-resistance in solid cancers N Hosseinkhani, MA Shadbad, M Asghari Jafarabadi, N Karim Ahangar, ... International Journal of Molecular Sciences 22 (19), 10389, 2021 | 17 | 2021 |
| A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The … M Abdoli Shadbad, N Hosseinkhani, Z Asadzadeh, A Derakhshani, ... Frontiers in Oncology 11, 689839, 2021 | 17 | 2021 |
| A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology MA Shadbad, Z Asadzadeh, N Hosseinkhani, A Derakhshani, N Alizadeh, ... Frontiers in immunology 12, 734956, 2021 | 12 | 2021 |
| The prognostic value of CD133 in predicting the relapse and recurrence pattern of high-grade gliomas on MRI: a meta-analysis M Abdoli Shadbad, N Hosseinkhani, Z Asadzadeh, O Brunetti, N Silvestris, ... Frontiers in Oncology 11, 722833, 2021 | 12 | 2021 |
| The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study A Derakhshani, Z Asadzadeh, B Baradaran, H Safarpour, S Rahmani, ... Biomedicine & Pharmacotherapy 148, 112725, 2022 | 10 | 2022 |
| The prognostic value of CD133 in predicting the relapse and recurrence pattern of high-grade gliomas on MRI: a meta-analysis MA Shadbad, N Hosseinkhani, Z Asadzadeh, O Brunetti, N Silvestris, ... Frontiers in Oncology 11, 2021 | 10 | 2021 |
| A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: a single-cell RNA sequencing-based study MA Shadbad, F Ghorbaninezhad, H Hassanian, NK Ahangar, ... Frontiers in Medicine 9, 1027758, 2022 | 8 | 2022 |
| B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview K Dolatkhah, N Alizadeh, H Mohajjel‐Shoja, M Abdoli Shadbad, ... International Journal of Rheumatic Diseases 25 (3), 259-271, 2022 | 6 | 2022 |
| Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development N Hosseinkhani, N Hemmat, E Baghbani, A Baghbanzadeh, T Kazemi, ... Gene 896, 148043, 2024 | 2 | 2024 |
| A Systematic Review to Clarify the and Prognostic CD44+ CD24-Values Phenotype of CD44 in Triple-Negative Breast Cancer MA Shadbad, N Hosseinkhani, Z Asadzadeh Chemoresistance and Metastasis in Breast Cancer: Molecular Mechanisms and …, 2022 | | 2022 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
